1. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
    Razan Sheta et al, 2019, International Journal of Molecular Sciences CrossRef
  2. Renal antiporter ClC-5 regulates collagen I/IV through the β-catenin pathway and lysosomal degradation
    Mònica Durán et al, 2024, Life Science Alliance CrossRef
  3. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer
    Mei Guo et al, 2020, International Immunopharmacology CrossRef
  4. Evaluating pretreatment serum CA-125 levels as prognostic biomarkers in endometrial cancer: a comprehensive meta-analysis
    Zhong Yu et al, 2024, Frontiers in Oncology CrossRef
  5. Salivary Transmembrane Mucins of the MUC1 Family (CA 15-3, CA 27.29, MCA) in Breast Cancer: The Effect of Human Epidermal Growth Factor Receptor 2 (HER2)
    Elena I. Dyachenko et al, 2024, Cancers CrossRef
  6. MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
    Wenqing Chen et al, 2021, International Journal of Molecular Sciences CrossRef
  7. Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer
    Mukulika Bose et al, 2023, Translational Research CrossRef
  8. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma
    Hongyu Xu et al, 2024, Annals of Medicine CrossRef
  9. The Role of MUC1 in Renal Cell Carcinoma
    Martina Milella et al, 2024, Biomolecules CrossRef
  10. The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy
    Mei Guo et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  11. MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research
    Xin Chen et al, 2019, BMC Cancer CrossRef
  12. MUC1: An emerging target in cancer treatment and diagnosis
    Liangliang Qing et al, 2022, Bulletin du Cancer CrossRef